A recent study indicates that patients who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.
Published data in a prominent health publication demonstrates that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month once they quit.
"Users purchasing these treatments should be aware of the risk of fast rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment weight within about a year and a half.
Analyzing Approaches
The study, which reviewed dozens of studies involving thousands of participants, contrasted the effects of these new drugs with other pills.
Scientists emphasize that people who shed pounds through diet and exercise generally have a less rapid weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Regain
Doctors suggest the way of the injections accounts for the amplified regain.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication leads to hunger is no longer kept in check, making binge eating far more likely."
An Ongoing Disease?
The NHS advise the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, considering the high risk of relapse, the treatment should be considered life-long.
This opinion is reinforced by drug manufacturers, who state that the findings "emphasize the chronic nature of excess weight," similar to managing conditions like hypertension.
User Experiences
Users who have stopped the jabs describe a sudden resurgence of appetite.
"It felt as if a trigger that goes on and you're instantly starving," recalled one woman.
This challenge is exacerbated if patients have not developed permanent dietary or behavioural modifications during treatment.
Significant Interest
Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while the jabs are potent tools for weight loss, they are not a standalone fix and maintained weight loss hinges on ongoing behavioural support.
